Pearl River Capital’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,839	Closed	-$262K	–	103
2024 Q2	$262K	Buy	+4,839	New	+$262K	0.04%	366
2022 Q4	–	Sell	-5,341	Closed	-$259K	–	520
2022 Q3	$259K	Buy	+5,341	New	+$259K	0.05%	399